Nextage Therapeutics Stock Market Capitalization
MCTC Stock | ILA 71.90 2.20 2.97% |
Nextage Therapeutics fundamentals help investors to digest information that contributes to Nextage Therapeutics' financial success or failures. It also enables traders to predict the movement of Nextage Stock. The fundamental analysis module provides a way to measure Nextage Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nextage Therapeutics stock.
Nextage |
Nextage Therapeutics Company Market Capitalization Analysis
Nextage Therapeutics' Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Nextage Therapeutics Market Capitalization | 9.54 M |
Most of Nextage Therapeutics' fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nextage Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Competition |
Based on the recorded statements, the market capitalization of Nextage Therapeutics is about 9.54 M. This is 99.93% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The market capitalization for all Israel stocks is 99.95% higher than that of the company.
Nextage Therapeutics is considered to be number one stock in market capitalization category among related companies. Market capitalization of Health Care industry is now estimated at about 260.88 Million. Nextage Therapeutics holds roughly 9.54 Million in market capitalization claiming about 4% of equities under Health Care industry.Nextage Fundamentals
Return On Asset | -0.37 | |||
Profit Margin | (2.30) % | |||
Operating Margin | (9.71) % | |||
Shares Outstanding | 2.27 M | |||
Shares Owned By Insiders | 22.39 % | |||
Shares Owned By Institutions | 0.02 % | |||
Price To Earning | (91.98) X | |||
Price To Book | 4.68 X | |||
Price To Sales | 26.11 X | |||
Revenue | 297 K | |||
Gross Profit | 207 K | |||
EBITDA | (5.38 M) | |||
Net Income | (2.09 M) | |||
Cash And Equivalents | 358 K | |||
Cash Per Share | 0.16 X | |||
Debt To Equity | 65.70 % | |||
Current Ratio | 0.44 X | |||
Book Value Per Share | 0.90 X | |||
Cash Flow From Operations | (5 M) | |||
Earnings Per Share | (0.24) X | |||
Beta | 1.05 | |||
Market Capitalization | 9.54 M | |||
Total Asset | 6.01 M | |||
Retained Earnings | (103 M) | |||
Working Capital | 1000 K | |||
Current Asset | 3 M | |||
Current Liabilities | 2 M | |||
Z Score | -23.8 | |||
Net Asset | 6.01 M |
About Nextage Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nextage Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nextage Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nextage Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nextage Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Nextage Stock analysis
When running Nextage Therapeutics' price analysis, check to measure Nextage Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nextage Therapeutics is operating at the current time. Most of Nextage Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nextage Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nextage Therapeutics' price. Additionally, you may evaluate how the addition of Nextage Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |